Breast Implant Market by Product, Shape, Application, End User, Regions and Company Analysis 2024-2032

The breast Implant Market is projected to grow to US$4.45 billion by 2032 from US$2.32 billion in 2023, growing at a CAGR of 7.5% from 2024 to 2032.

Breast enlargement, also known as breast augmentation, involves placing an implant under the breast tissue to increase its size and shape. The implants can be inserted through incisions under the breast, in the armpit, or around the nipple. They can be positioned directly behind the breast, on top of the chest wall muscle, or behind the breast and chest wall muscle (sub-muscular). Breast implants are used for augmentation, reconstruction, and to improve the appearance of the breasts.

The field of breast implantation surgery has advanced substantially due to the increasing demand for cosmetic procedures. Many women who wish to enhance their appearance contribute considerably to the revenue of the breast implantation market. According to the FDA, women over the age of 18 are eligible for breast augmentation surgeries. In India alone, over 10,000 breast implantations are performed annually, and globally, more than 1.6 million augmentation procedures were carried out in 2023, making it one of the most popular cosmetic procedures worldwide.

The breast implant market is expanding due to the increasing prevalence of breast cancer. In severe cases, preventing this disease may require mastectomy surgery, which involves the removal of the entire organ. Reconstruction of the organ is a valuable option for treating such disease, involving reshaping the removed organ. In 2022, 2.3 million women were diagnosed with breast cancer, resulting in 670,000 deaths worldwide. It is estimated that in 2023, the number of new cases was 2,97,790 of invasive breast cancer will be diagnosed in U.S. women, along with 55,720 new cases of DCIS. As the number of reconstruction cases rises, there is an increasing demand for breast implantation over the forecast period.

Market players in the area are constantly developing better and more efficient solutions and improving the quality of available products through awareness campaigns about breast implants, product launches, collaborations, and mergers and acquisitions, all of which will support market growth. In June 2023, VSS Capital Partners, an investment firm focusing on healthcare, education, and business services, announced an investment in Olympus Cosmetic Group, a new platform offering comprehensive cosmetic surgery, dermatological treatments, and non-surgical cosmetic procedures. The introduction of advanced breast implants is expected to contribute to the market's growth.

North America Breast Implant Market

The breast implant market in North America is significant, with the United States poised to dominate. This dominance is driven by the high demand for cosmetic surgeries and procedures among women, with breast augmentation ranking among the leading five cosmetic surgical procedures in the United States in 2023. This trend underscores the potential for growth and investment opportunities in the region.

The American Cancer Society reports that breast cancer accounts for about 30% of all new female cancer cases in the US annually. In 2023, it is estimated that there will be about 297,790 new cases of invasive breast cancer and 55,720 new cases of DCIS diagnosed in the US. Additionally, in 2022, 28,600 Canadian women were diagnosed with breast cancer, making up 25% of all new cancer cases in women in Canada.

In October 2022, the American College of Radiology initiated the CMIST trial in partnership with the Breast Cancer Research Foundation and GE Healthcare. The University of Texas MD Anderson Cancer Center and the World Health Organization (WHO) also formed an international collaboration to address the global impact of women's cancers.

Breast Implant Company Analysis:

Some major companies are present in the global breast implant industry. These are Abbvie Inc., Sientra Inc., Hans Biomed Co., Ltd, Establishment Labs SA, Guangzhou Wanhe Plastic Materials Co., Ideal Implant Inc., Laboratoires Arion, Polytech Health & Aesthetics GmbH, Mentor Worldwide LLC and Sebbin.

Breast Implant Company News:

June 2023: Olympus Cosmetic Group, a recently established platform offering comprehensive cosmetic surgery, dermatological treatments, and non-surgical cosmetic procedures, recently received an investment from VSS Capital Partners.

November 2023: Allergan Aesthetics, an AbbVie subsidiary, acknowledges the enormously personal choice that patients experience when selecting breast surgery. The new Natrelle(R) campaign, "For Every BODY," celebrates patients and their stories using new imagery and visual assets. The campaign illustrates how any curve, shape, and BODY can have a personalized look with the Natrelle(R) breast implant collection.

October 2022: GC Anesthetics received CE approval for the micro-textured anatomical breast implant LUNA tx, allowed under the new European Medical Device Regulation (MDR).

June 2022: To meet breast reconstruction needs, Coll Plant announced the commencement of research in large animals for its 3D bio-printed regenerative breast implant program.

January 2022: The FDA has approved Mentor Worldwide LLC's MENTO MemoryGel BOOST breast implant for breast augmentation in women 22 and older.

Product- Market breakup in 2 viewpoints:

1. Silicone Implants

2. Saline Implants

Shape - Market breakup in 2 viewpoints:

1. Round

2. Anatomical

Application- Market breakup in 2 viewpoints:

1. Breast Cosmetic Surgery

2. Breast Reconstruction Surgery

End User- Market breakup in 2 viewpoints:

1. Hospitals

2. Cosmetology Clinics

Country - Market breakup of 17 Countries:

1. United States

2. Brazil

3. Japan

4. Mexico

5. Turkey

6. Germany

7. Argentina

8. Italy

9. Colombia

10. India

11. Spain

12. Greece

13. Iran

14. Romania

15. United Kingdom

16. Thailand

17. Rest of the World

All the key players have been covered from 4 Viewpoints:

• Business Overview
• Product Portfolio
• Recent Development
• Revenue Analysis

Key Players Analysis:

1. Abbvie

2. Sientra Inc.

3. Hans Biomed Co., Ltd

4. Establishment Labs SA

5. Guangzhou Wanhe Plastic Materials Co.

6. Ideal Implant Inc.

7. Laboratoires Arion

8. Polytech Health & Aesthetics GmbH

9. Mentor Worldwide LLCs

10. Sebbin